The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer.
Ryan Quiroz,Michael H. Reutershan,Sebastian E. Schneider,David Sloman,Brian M. Lacey, Brooke M. Swalm,Charles S. Yeung,Craig Gibeau,Daniel S. Spellman,Danica A. Rankic,Dapeng Chen,David Witter,Doug Linn,Erik Munsell,Guo Feng, Haiyan Xu,Jonathan M. E. Hughes,Jongwon Lim,Josep Sauri,Kristin Geddes, Murray Wan,My Sam Mansueto, Nicole E. Follmer,Patrick S. Fier,Phieng Siliphaivanh,Pierre Daublain,Rachel L. Palte,Robert P. Hayes,Sandra Lee,Shuhei Kawamura,Steven Silverman,Sulagna Sanyal,Timothy J. Henderson,Yingchun Ye, Yuanwei Gao,Benjamin Nicholson,Michelle R. Machacek Journal of Medicinal Chemistry（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper